Holland & Knight LLP advised Piper Sandler & Co. and Stephens Inc. on the deal. Piper Sandler & Co. and Stephens Inc. acted as underwriters of...
Mid Penn Bancorp’s $74.75 Million Public Offering
Privia Health Group’s $607.8 IPO
Goodwin Procter LLP advised the underwriters on the deal. Privia Health Group, Inc. (“Privia Health”) (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with...
EDAP TMS’s $28 Million Public Offering
Davis Polk advised the underwriters in the offering, while Jones Day advised EDAP. EDAP TMS S.A. executed its $28 million public offering of 4,150,000 American depositary shares,...
EDAP TMS’s $28 Million Public Offering
IN BRIEF: Davis Polk & Wardwell, Jones Day, advised on the matter. Davis Polk & Wardwell advised B. Riley Securities, Lake Street Capital Markets LLC, Piper...
Rain Therapeutics’ $125 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...
Phreesia’s $245.3 Million Common Stock Offering
Latham & Watkins LLP represented the underwriters in the offering. Phreesia, Inc., a leading patient intake management platform, has announced the closing of the underwritten public...
Reneo Pharmaceuticals’ $93.8 Million Initial Public Offering
Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. has announced the pricing...
ACV Auctions’ $475.8 Million Initial Public Offering
Davis Polk advised representatives of several underwriters in the offering. ACV Auctions Inc. executed the $475.8 million initial public offering of 19,032,500 shares of Class A common...
Achilles Therapeutics’ $175.5 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing...
ThredUp Inc.’s $168 Million IPO
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal. ThredUp Inc. (thredUP) announced the pricing of its initial public offering of 12,000,000 shares of...
Solid Biosciences’ $143.75 Million Equity Offering
Davis Polk advised the joint book-running managers in the offering. Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed...
Array Technologies’ $993 Million Secondary Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. The $993 million secondary offering of 35,475,457 shares of common stock of...